John Fesko Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 8 hours ago
John Fesko has an estimated net worth of at least $50.2 million*, as of March 18, 2026. They own 189,199 shares of NTRA stock. They have sold 74,261 shares of NTRA stock since 2021, for an estimated $12.9 million.
John Fesko $NTRA SEC Form 4 Insider Trading
John Fesko has filed a total of 41 insider trades in $NTRA since 2021. Their most recent trade was a sale of 707 shares, made on Mar 10, 2026. Their largest trade was a sale of 21,175 shares, made on Jan 22, 2025. We estimate that they now own 189,199 shares of $NTRA, worth an estimated $37.3 million.
Insider Trading at $NTRA
There have been a total of 1149 insider trades reported at $NTRA since 2021, with 375,220 shares purchased and 4.8 million shares sold. The most active insider traders in $NTRA stock have been Steven Leonard Chapman, Michael Burkes Brophy, and Daniel Rabinowitz. The most recent trade was a sale of 239 shares reported by Jonathan Sheena (None), made on Mar 20, 2026.
History of Insider Stock Trades by John Fesko
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
NTRA
|
Sale | 707 | Mar 10, 2026 | March 11, 2026, 9:05 p.m. |
NTRA
|
Sale | 1,179 | Feb 03, 2026 | Feb. 4, 2026, 10:05 p.m. |
NTRA
|
Sale | 2,415 | Feb 03, 2026 | Feb. 4, 2026, 10:05 p.m. |
NTRA
|
Sale | 784 | Jan 27, 2026 | Jan. 29, 2026, 9:35 p.m. |
NTRA
|
Sale | 928 | Jan 28, 2026 | Jan. 29, 2026, 9:35 p.m. |
NTRA
|
Sale | 17,806 | Jan 20, 2026 | Jan. 22, 2026, 10:05 p.m. |
NTRA
|
Sale | 339 | Jan 21, 2026 | Jan. 22, 2026, 10:05 p.m. |
NTRA
|
Sale | 781 | Oct 27, 2025 | Oct. 29, 2025, 9:05 p.m. |
NTRA
|
Sale | 928 | Oct 28, 2025 | Oct. 29, 2025, 9:05 p.m. |
NTRA
|
Sale | 339 | Oct 21, 2025 | Oct. 22, 2025, 9:05 p.m. |
NTRA
|
Sale | 6 | Aug 14, 2025 | Aug. 15, 2025, 9:35 p.m. |
NTRA
|
Sale | 672 | Aug 14, 2025 | Aug. 15, 2025, 9:35 p.m. |
NTRA
|
Sale | 1,710 | Jul 28, 2025 | July 30, 2025, 9:35 p.m. |
NTRA
|
Sale | 1,438 | May 27, 2025 | July 22, 2025, 9:05 p.m. |
NTRA
|
Sale | 339 | Jul 21, 2025 | July 22, 2025, 9:05 p.m. |
NTRA
|
Sale | 1,709 | Apr 28, 2025 | April 30, 2025, 9:35 p.m. |
NTRA
|
Sale | 4 | Apr 21, 2025 | April 22, 2025, 9:35 p.m. |
NTRA
|
Sale | 339 | Apr 21, 2025 | April 22, 2025, 9:35 p.m. |
NTRA
|
Sale | 793 | Mar 17, 2025 | March 19, 2025, 9:35 p.m. |
NTRA
|
Sale | 2 | Mar 17, 2025 | March 19, 2025, 9:35 p.m. |
NTRA
|
Sale | 663 | Feb 06, 2025 | Feb. 7, 2025, 10:35 p.m. |
NTRA
|
Sale | 2 | Jan 29, 2025 | Jan. 31, 2025, 10:35 p.m. |
NTRA
|
Sale | 913 | Jan 29, 2025 | Jan. 31, 2025, 10:35 p.m. |
NTRA
|
Sale | 3,115 | Jan 29, 2025 | Jan. 31, 2025, 10:35 p.m. |
NTRA
|
Sale | 21,175 | Jan 22, 2025 | Jan. 24, 2025, 10:45 p.m. |
NTRA
|
Sale | 53 | Jan 22, 2025 | Jan. 24, 2025, 10:45 p.m. |
NTRA
|
Sale | 668 | Dec 23, 2024 | Dec. 26, 2024, 10:05 p.m. |
NTRA
|
Sale | 1 | Dec 23, 2024 | Dec. 26, 2024, 10:05 p.m. |
NTRA
|
Sale | 929 | Oct 28, 2024 | Oct. 30, 2024, 9:35 p.m. |
NTRA
|
Sale | 199 | Oct 22, 2024 | Oct. 23, 2024, 9:35 p.m. |
NTRA
|
Sale | 342 | Oct 21, 2024 | Oct. 23, 2024, 9:35 p.m. |
NTRA
|
Sale | 3,956 | Aug 13, 2024 | Aug. 14, 2024, 9:05 p.m. |
NTRA
|
Sale | 929 | Jul 29, 2024 | July 31, 2024, 9:05 p.m. |
NTRA
|
Sale | 549 | Jul 22, 2024 | July 23, 2024, 9:05 p.m. |
NTRA
|
Sale | 1,438 | May 28, 2024 | May 30, 2024, 9:05 p.m. |
NTRA
|
Sale | 929 | Apr 29, 2024 | May 1, 2024, 9:05 p.m. |
NTRA
|
Sale | 522 | Apr 23, 2024 | April 23, 2024, 9:35 p.m. |
NTRA
|
Sale | 464 | Mar 28, 2024 | March 29, 2024, 9:35 p.m. |
NTRA
|
Sale | 15 | Mar 05, 2024 | March 7, 2024, 10:40 p.m. |
NTRA
|
Sale | 1,823 | Mar 05, 2024 | March 7, 2024, 10:40 p.m. |
NTRA
|
Sale | 2,358 | Jan 29, 2024 | Jan. 30, 2024, 9:57 p.m. |
$NTRA Executives and Stock Owners with Insider Trades
-
Steven Leonard Chapman, CEO AND PRESIDENT
-
Michael Burkes Brophy, CHIEF FINANCIAL OFFICER
-
Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER
-
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS
-
Matthew Rabinowitz, EXECUTIVE CHAIRMAN
-
John Fesko, PRESIDENT, CHIEF BUS. OFFICER
-
Robert Alan Schueren, CHIEF OPERATING OFFICER
-
Daniel Rabinowitz, CHIEF LEGAL OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.